Mindfulness-based Lifestyle Modification Programme for Caregivers of People With Neurodegenerative Disorders

Launched by THE UNIVERSITY OF HONG KONG · Aug 30, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a program called "B-Mindful-Life," which aims to help caregivers of people with neurodegenerative diseases (like Alzheimer’s or Parkinson’s) increase their physical activity. Caregivers often face high levels of stress and physical inactivity, which can lead to serious health issues. This trial is testing a mindfulness-based approach that combines lifestyle counseling with mobile messaging to provide support and guidance. The goal is to see if this program can encourage caregivers to be more active and improve their overall well-being.

To participate in the trial, you need to be an adult who has been a primary caregiver for someone with a neurodegenerative disease for at least three months and is experiencing moderate stress. You should also have access to a mobile device with the internet and be able to read and communicate in Chinese. During the trial, participants will engage in the program and monitor their physical activity over a week using a device that tracks movement. This research is important because it seeks to find effective ways to support caregivers in maintaining their health while they take care of others.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • adults who self-identify as the primary caregivers of ND patients for ≥3 months,
• • experience of at least moderate stress as indicated by a PSS score ≥14,
• • have a mobile device (e.g., smartphone, tablet, and laptop) with Internet access, and
• • able to read and communicate in Chinese and give written consent
• Exclusion Criteria:
• • a self-reported exercise regimen of great than 150 minutes/week of MVPA (according to the American College of Sports Medicine guidelines),
• • have received (within the past 6 months) or are receiving other physical and/or psychosocial interventions,
• • pregnancy or within 6 months of postpartum,
• • contraindications (e.g., current diagnosis of psychiatric illness according to the DSM IV-TR, DSM-V, or ICD-10) or severe comorbidities (e.g., severe hearing/vision/cognitive impairment) that might limit full participation.